These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 19564138

  • 1. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V, Khanna A, Venkatpurwar V, Dhar S, Mandpe L.
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [Abstract] [Full Text] [Related]

  • 2. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V, Dhar S, Mandpe L.
    Hindustan Antibiot Bull; 2009 Jun; 49-50(1-4):21-8. PubMed ID: 19957540
    [Abstract] [Full Text] [Related]

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 4. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P, Sebe I, Stiedl B, Kállai-Szabó B, Zelkó R.
    J Pharm Biomed Anal; 2015 Nov 10; 115():359-67. PubMed ID: 26280924
    [Abstract] [Full Text] [Related]

  • 5. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
    Cappello B, De Rosa G, Giannini L, La Rotonda MI, Mensitieri G, Miro A, Quaglia F, Russo R.
    Int J Pharm; 2006 Aug 17; 319(1-2):63-70. PubMed ID: 16650700
    [Abstract] [Full Text] [Related]

  • 6. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P.
    Drug Dev Ind Pharm; 2005 Aug 17; 31(7):697-707. PubMed ID: 16207617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C, Prabhakar B.
    Drug Dev Ind Pharm; 2015 Aug 17; 41(10):1589-607. PubMed ID: 25350555
    [Abstract] [Full Text] [Related]

  • 9. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
    Srikanth Meka V, Wee Liang VA, Dharmalingham SR, Sheshala R, Gorajana A.
    Acta Pharm; 2014 Dec 17; 64(4):485-94. PubMed ID: 25531788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS, Vavia PR.
    Int J Pharm; 2008 Mar 20; 352(1-2):5-16. PubMed ID: 18023545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K, Khanam J.
    J Pharm Biomed Anal; 2014 Aug 05; 96():10-20. PubMed ID: 24705456
    [Abstract] [Full Text] [Related]

  • 15. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C, Aiassa V, Longhi M.
    J Pharm Biomed Anal; 2012 Apr 07; 63():74-9. PubMed ID: 22361661
    [Abstract] [Full Text] [Related]

  • 16. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH, Bandari S, Jukanti R, Veerareddy PR.
    Arch Pharm Res; 2011 Jan 07; 34(1):51-7. PubMed ID: 21468915
    [Abstract] [Full Text] [Related]

  • 17. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
    Alonso EC, Riccomini K, Silva LA, Galter D, Lima EM, Durig T, Taveira SF, Martins FT, Cunha-Filho MS, Marreto RN.
    J Pharm Pharmacol; 2016 Oct 07; 68(10):1299-309. PubMed ID: 27465985
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.
    Planinšek O, Kovačič B, Vrečer F.
    Int J Pharm; 2011 Mar 15; 406(1-2):41-8. PubMed ID: 21219991
    [Abstract] [Full Text] [Related]

  • 19. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 15; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 20. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
    Lv HX, Zhang ZH, Hui-Jiang, Waddad AY, Zhou JP.
    Pharmazie; 2012 Jan 15; 67(1):46-53. PubMed ID: 22393830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.